Skip to main content
Clinical Trials/NCT06024564
NCT06024564
Terminated
Not Applicable

Sonu Real-World Use Clinical Study to Treat Moderate to Severe Nasal Congestion

Third Wave Therapeutics1 site in 1 country121 target enrollmentAugust 8, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Nasal Congestion
Sponsor
Third Wave Therapeutics
Enrollment
121
Locations
1
Primary Endpoint
Weekly Utilization-Frequency
Status
Terminated
Last Updated
last year

Overview

Brief Summary

Real world utilization of Acoustic Resonance Therapy for symptoms of Nasal Congestion

Detailed Description

This is an interventional study designed to gather data on real world utilization of Acoustic Resonance Therapy for treating moderate to severe nasal congestion

Registry
clinicaltrials.gov
Start Date
August 8, 2023
End Date
August 31, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Third Wave Therapeutics
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 18 years of age and older
  • Present with symptoms of chronic nasal congestion
  • Have a 24 hour reflective nasal congestion subscore of the TNSS of 2 or more on a 0 to 3 scale at the time of screening

Exclusion Criteria

  • Head, nasal or sinus surgery within 3 months
  • Pregnancy

Outcomes

Primary Outcomes

Weekly Utilization-Frequency

Time Frame: 90 days

Weekly utilization of Sonu treatment, measured as the frequency or number of times used per week

Weekly Utilization-Duration

Time Frame: 90 days

Weekly utilization of Sonu treatment, measured as the duration of treatment received per week

Secondary Outcomes

  • Total Nasal Symptom Score (TNSS)(90 days)
  • Asthma Control(90 days)

Study Sites (1)

Loading locations...

Similar Trials